Lau Associates Has Trimmed Its Johnson & Johnson (JNJ) Position; Sjw Group (de) (SJW) Shorts Decreased By 6.51%

March 23, 2018 - By Peter Erickson

Lau Associates Llc decreased Johnson & Johnson (JNJ) stake by 4.23% reported in 2017Q3 SEC filing. Lau Associates Llc sold 2,535 shares as Johnson & Johnson (JNJ)’s stock rose 6.85%. The Lau Associates Llc holds 57,338 shares with $7.46M value, down from 59,873 last quarter. Johnson & Johnson now has $341.72 billion valuation. The stock decreased 2.90% or $3.81 during the last trading session, reaching $127.38. About 7.56 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since March 23, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Sjw Group (de) (NYSE:SJW) had a decrease of 6.51% in short interest. SJW’s SI was 90,500 shares in March as released by FINRA. Its down 6.51% from 96,800 shares previously. With 56,500 avg volume, 2 days are for Sjw Group (de) (NYSE:SJW)’s short sellers to cover SJW’s short positions. The SI to Sjw Group (de)’s float is 0.57%. The stock decreased 0.80% or $0.43 during the last trading session, reaching $53.21. About 120,482 shares traded or 44.44% up from the average. SJW Group (NYSE:SJW) has risen 43.57% since March 23, 2017 and is uptrending. It has outperformed by 26.87% the S&P500.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on April, 17. They expect $2.01 earnings per share, up 9.84% or $0.18 from last year’s $1.83 per share. JNJ’s profit will be $5.39B for 15.84 P/E if the $2.01 EPS becomes a reality. After $1.74 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts 15.52% EPS growth.

Investors sentiment increased to 0.87 in 2017 Q3. Its up 0.04, from 0.83 in 2017Q2. It is positive, as 45 investors sold JNJ shares while 871 reduced holdings. 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. Moreover, Williams Jones Ltd has 2.09% invested in Johnson & Johnson (NYSE:JNJ). Boulegeris Investments has 123,594 shares for 8.93% of their portfolio. Lsv Asset Mgmt stated it has 2.11% in Johnson & Johnson (NYSE:JNJ). 20,374 are held by Altfest L J. Weaver C Barksdale, Tennessee-based fund reported 11,558 shares. Regal Invest Advisors Limited reported 36,573 shares. Town & Country Bank & Trust Company Dba First Bankers Trust Company invested in 2.32% or 34,431 shares. Veritas Ltd Liability Partnership, a United Kingdom-based fund reported 3,530 shares. Dean Invest Assocs Limited Liability Company, a Ohio-based fund reported 52,940 shares. 30,734 were accumulated by Oxbow Advsrs Lc. M Holding Securities reported 0.87% in Johnson & Johnson (NYSE:JNJ). Inr Advisory Ser Limited Liability Corporation has invested 0.01% in Johnson & Johnson (NYSE:JNJ). Arrow Fincl Corp owns 1.86% invested in Johnson & Johnson (NYSE:JNJ) for 60,355 shares. Cheviot Value Mgmt Llc, a California-based fund reported 103,886 shares. Security Bank & Trust Of So Dak reported 2.35% in Johnson & Johnson (NYSE:JNJ).

Since February 15, 2018, it had 0 insider buys, and 1 insider sale for $20.17 million activity. Stoffels Paulus sold $20.17 million worth of Johnson & Johnson (NYSE:JNJ) on Thursday, February 15.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson has $170.0 highest and $90 lowest target. $137.35’s average target is 7.83% above currents $127.38 stock price. Johnson & Johnson had 91 analyst reports since August 7, 2015 according to SRatingsIntel. Goldman Sachs downgraded it to “Sell” rating and $130.0 target in Wednesday, September 20 report. The firm has “Hold” rating given on Friday, July 14 by Jefferies. The firm has “Outperform” rating given on Wednesday, January 25 by RBC Capital Markets. The stock has “Buy” rating by S&P Research on Wednesday, October 14. BTIG Research maintained Johnson & Johnson (NYSE:JNJ) rating on Tuesday, January 23. BTIG Research has “Sell” rating and $110.0 target. On Friday, July 21 the stock rating was downgraded by BTIG Research to “Sell”. Jefferies maintained the stock with “Hold” rating in Friday, June 16 report. The firm earned “Hold” rating on Monday, October 2 by Piper Jaffray. On Wednesday, January 24 the stock rating was maintained by Stifel Nicolaus with “Hold”. The firm has “Sell” rating by BTIG Research given on Wednesday, August 2.

Investors sentiment decreased to 0.8 in 2017 Q3. Its down 0.70, from 1.5 in 2017Q2. It is negative, as 9 investors sold SJW Group shares while 37 reduced holdings. 20 funds opened positions while 49 raised stakes. 11.04 million shares or 14.82% more from 9.61 million shares in 2017Q2 were reported. Messner And Smith Theme Value Invest Mngmt Limited Ca holds 7,740 shares. Nationwide Fund invested 0.01% of its portfolio in SJW Group (NYSE:SJW). Prudential holds 123,878 shares. Peak6 Invests L P reported 0% of its portfolio in SJW Group (NYSE:SJW). Ubs Asset Mgmt Americas has invested 0% in SJW Group (NYSE:SJW). Zacks Mngmt invested 0.04% in SJW Group (NYSE:SJW). Legal & General Group Public Limited Com accumulated 54,890 shares. Eqis Mngmt Incorporated reported 8,310 shares stake. Metropolitan Life Insurance Ny has invested 0% in SJW Group (NYSE:SJW). Dimensional Fund Advsrs L P owns 700,239 shares or 0.02% of their US portfolio. California Public Employees Retirement holds 22,372 shares. Axa accumulated 4,300 shares. Northern holds 0% of its portfolio in SJW Group (NYSE:SJW) for 231,915 shares. Panagora Asset Management owns 32,423 shares for 0.01% of their portfolio. Price T Rowe Assocs Inc Md invested in 8,367 shares or 0% of the stock.

Among 2 analysts covering SJW Corp (NYSE:SJW), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. SJW Corp had 3 analyst reports since February 22, 2016 according to SRatingsIntel. Robert W. Baird upgraded SJW Group (NYSE:SJW) on Monday, February 22 to “Outperform” rating. Janney Capital upgraded the shares of SJW in report on Friday, July 28 to “Buy” rating.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: